Bristol-Myers Squibb Company beats revenue forecasts & raises 2025 guidance. Click for key BMY catalysts, risks, and outlook ...

Zoryve’s regulatory and commercial success, together with pipeline progress, supports Arcutis Biotherapeutics’ positive Q2 ...

ETFs can help investors benefit from the higher income potential of MLPs while avoiding tax-related headaches.

MannKind Corporation (NASDAQ:MNKD) is one of the penny stocks that will skyrocket. On July 16, H.C. Wainwright assumed ...

Looking for the latest stock opportunities in August 2025? Click to read these top stock picks to consider adding to your ...

The MLP has added a lot more fuel to its growth engine this year. The latest addition is its nearly $2.4 billion acquisition ...

We recently published 13 Stocks That Jim Cramer Recently Talked About. Merck & Co., Inc. (NYSE:MRK) is one of the stocks Jim Cramer recently discussed.

Key Points Earnings per share (GAAP) missed expectations, posting a loss of $(0.40) for Q2 2025, compared to an estimated loss of $(0.04). Revenue (GAAP) fell 12.3% year-over-year in Q2 2025 to $377.3 ...

Silvercrest Asset Management Group Inc. (SAMG) Q2 2025 Management View CEO Richard R. Hough reported "discretionary assets under management increased $1 billion during the second quarter, primarily ...

On Friday, Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) reported second-quarter adjusted earnings of $12.89 per share, up 12% ...

Sharp increase in mainland buying comes as trading and fundraising activity in the city rebounds after a multi-year slump.

Foreign institutional investors are raising stakes in these government-backed companies. We explore what is fuelling the ...